About the journal
Breast Cancer: Basic and Clinical Research is an open-access journal published by SAGE Publishing in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,650 USD. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- SAGE Publishing
- ISSN
- 1178-2234
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,650 USD
- Articles in DOAJ
- 528
- Declared review time
- 8 weeks
- Declared peer-review model
- peer_review
- Official website
- https://journals.sagepub.com/home/bcb
Index listings
- DOAJ · 2008-04-17
- PUBMED · 2008-05-23
- Indexing
- DOAJ · PUBMED
- APC
- 2,650 USD
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
528
Most recent article
last month
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
378
Last recorded publication year
2026
h-index
46
i10-index
187
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2024-04-04
- Added to DOAJ
- 2008-04-17
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 82%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101474356
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Breast Lesions and Carcinomas
- Breast Lesions and Carcinomas
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
Show all subjects (50)
- Cancer Risks and Factors
- Cancer Risks and Factors
- Breast Implant and Reconstruction
- BRCA gene mutations in cancer
- Breast Implant and Reconstruction
- BRCA gene mutations in cancer
- Advanced Breast Cancer Therapies
- Advanced Breast Cancer Therapies
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Estrogen and related hormone effects
- Estrogen and related hormone effects
- Cancer survivorship and care
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Digital Radiography and Breast Imaging
- Digital Radiography and Breast Imaging
- Male Breast Health Studies
- Male Breast Health Studies
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
- Cancer-related Molecular Pathways
- MRI in cancer diagnosis
- MRI in cancer diagnosis
- Cancer-related Molecular Pathways
- Cancer, Lipids, and Metabolism
- AI in cancer detection
- Monoclonal and Polyclonal Antibodies Research
- AI in cancer detection
- Monoclonal and Polyclonal Antibodies Research
- Lymphatic System and Diseases
- Lymphatic System and Diseases
- Cancer, Stress, Anesthesia, and Immune Response
- Cancer-related cognitive impairment studies
- Cancer and Skin Lesions
- Cancer-related cognitive impairment studies
- Cancer, Stress, Anesthesia, and Immune Response
- Cancer and Skin Lesions
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
Keywords (DOAJ)
- cancer
- breast surgery
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ